Clinical Trials on Relapsed/Refractory Hodgkin's Lymphoma in Singapore
Total 74 results
-
AstraZenecaCompletedRelapsed/Refractory Peripheral T-cell Lymphoma | Relapsed/Refractory Classical Hodgkins LymphomaItaly, Sweden, United States, Taiwan, Korea, Republic of, United Kingdom, Australia, France, Singapore
-
National Cancer Centre, SingaporeMerck Sharp & Dohme LLC; National Medical Research Council (NMRC), SingaporeNot yet recruitingRefractory Peripheral T-Cell Lymphoma | Relapsed Peripheral T-Cell LymphomaSingapore
-
National University Hospital, SingaporeCompleted
-
Novartis PharmaceuticalsActive, not recruitingChronic Lymphocytic Leukemia | Non-Hodgkins LymphomaSpain, Korea, Republic of, Israel, Japan, Germany, Singapore, Finland
-
Singapore General HospitalNational University Hospital, Singapore; National Cancer Center Singapore,... and other collaboratorsWithdrawnEBV Related Non-Hodgkin's Lymphoma | Primary CNS Lymphoma | Primary Testicular LymphomaSingapore
-
Novartis PharmaceuticalsRecruitingB-cell Non-Hodgkin Lymphoma (B-NHL) | B-cell Acute Lymphoblastic Leukemia (B-ALL)Japan, Italy, Spain, Belgium, Singapore, France, Israel, United States
-
Singapore General HospitalNational Medical Research Council (NMRC), SingaporeCompletedAcute Myeloid Leukemia | Multiple Myeloma | Acute Lymphoblastic Leukemia | Chronic Myeloid Leukemia | Myelodysplastic Syndrome | Non Hodgkin's Lymphoma | Hodgkin's DiseaseSingapore
-
Novartis PharmaceuticalsXOMA (US) LLCCompletedHodgkin's Lymphoma | Non-Hodgkin's LymphomaUnited States, Belgium, Canada, Italy, France, Hong Kong, Australia, United Kingdom, Singapore, Korea, Republic of, Germany
-
Gilead SciencesTerminatedIndolent Non-Hodgkin's LymphomasUnited States, Korea, Republic of, Hungary, United Kingdom, Australia, Singapore, Japan, Taiwan, Israel, Italy, Spain, Czechia, Russian Federation, France, Poland, Romania, Germany, Portugal, Sweden
-
PfizerCompletedHodgkin Disease | Thrombocytopenia | Non-Hodgkin LymphomaUnited States, Russian Federation, Singapore, Australia, France, Hong Kong, Greece, Poland
-
Singapore General HospitalCelgeneUnknown
-
Singapore General HospitalJanssen, LPRecruitingDiffuse Large B Cell Lymphoma | Diffuse Large B-Cell Lymphoma RecurrentSingapore
-
National Cancer Centre, SingaporeCompletedPeripheral T-cell LymphomaSingapore
-
National Cancer Centre, SingaporeSamsung Medical Center; Singapore General HospitalTerminatedLymphoma, B-Cell, Marginal ZoneSingapore
-
National Cancer Centre, SingaporeBristol-Myers SquibbWithdrawnNK/T Cell LymphomaSingapore
-
CytoMed Therapeutics Pte LtdNational University Hospital, SingaporeNot yet recruitingCancer | Malignancy | Relapsed Cancer | Refractory CancerSingapore
-
National Cancer Centre, SingaporeTerminatedExtranodal NK-T-CELL LYMPHOMASingapore
-
Singapore General HospitalJanssen-Cilag Ltd.CompletedDiffuse Large B-Cell LymphomaSingapore
-
National Cancer Centre, SingaporeGlaxoSmithKlineCompletedDiffuse Large B-cell LymphomaSingapore
-
National University Hospital, SingaporeNational University of SingaporeUnknownPilot Study of Autologous T Lymphocytes With ADCC in Patients With CD20-Positive B-Cell MalignanciesNon-Hodgkin's Lymphoma | B-Cell Chronic Lymphocytic LeukemiaSingapore
-
Institut de Recherches Internationales ServierADIR, a Servier Group companyCompletedChronic Lymphocytic Leukaemia (CLL) | Multiple Myeloma (MM) | B-Cell Non-Hodgkin Lymphoma (NHL)France, Australia, Germany, Korea, Republic of, United Kingdom, Hungary, Poland, Singapore
-
Novartis PharmaceuticalsCompletedHodgkin's LymphomaUnited States, Belgium, Germany, Canada, Singapore, Netherlands, France, Australia, Russian Federation, Israel, Brazil, Italy, New Zealand, Poland
-
Novartis PharmaceuticalsCompletedClassical Hodgkin's LymphomaSpain, France, Belgium, Italy, Israel, Germany, United States, Australia, Brazil, Singapore, Malaysia, New Zealand, United Kingdom
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Refractory Follicular Lymphoma | Grade 3a Follicular LymphomaUnited States, Canada, Singapore
-
Nordic NanovectorICON Clinical ResearchActive, not recruitingFollicular Lymphoma | Non-Hodgkin LymphomaUnited States, Korea, Republic of, Australia, Austria, Belgium, Canada, Croatia, Czechia, Denmark, Finland, France, Hungary, Ireland, Israel, Italy, Netherlands, Norway, Poland, Singapore, Spain, Sweden, Switzerland, Turkey, United Kingdom
-
PfizerUCB PharmaCompletedLymphoma, B-CellKorea, Republic of, Canada, Belgium, Singapore, United States, Hong Kong, Japan, United Kingdom, France
-
PfizerUCB PharmaCompletedLymphomaUnited States, Belgium, Japan, Korea, Republic of, Germany, Hong Kong, Hungary, Netherlands, Singapore
-
National University Hospital, SingaporeRecruitingLymphoblastic Leukemia, Acute, Childhood | Lymphoblastic Leukemia | Lymphoblastic Leukemia, Acute Adult | Lymphoblastic Leukemia in Children | CAR | CAR T-Cell-Related Encephalopathy Syndrome | Refractory LeukemiaSingapore
-
Dren BioNovotech (Australia) Pty LimitedRecruitingB-cell Non Hodgkin LymphomaAustralia, Hong Kong, Korea, Republic of, Singapore, Taiwan
-
BayerCompletedNon-Hodgkin's Lymphoma | Mantle Cell Lymphoma | Advanced Solid TumorUnited States, Canada, China, Japan, Singapore, United Kingdom, Switzerland
-
St. Jude Children's Research HospitalActive, not recruitingMature B-Cell LymphomaUnited States, Singapore, Egypt
-
Singapore General HospitalCompletedAngioimmunoblastic T-cell Lymphoma | Hepatosplenic T-cell Lymphoma | Peripheral T-cell Lymphoma (Not Otherwise Specified) | Extranodal NK/T-cell Lymphoma Nasal Type | Enteropathy- Type T-cell Lymphoma | Anaplastic Large Cell Lymphoma (ALCL) (ALK-1 Negative) | Relapsed ALCL (ALK-1 Positive) Post...Singapore, Malaysia, Korea, Republic of
-
Karyopharm Therapeutics IncTerminatedCutaneous T-cell Lymphoma (CTCL) | Peripheral T-cell Lymphoma (PTCL)Australia, Singapore
-
Hoffmann-La RocheCompletedNon-Hodgkin's LymphomaItaly, United Kingdom, Belgium, Brazil, Denmark, France, Peru, Colombia, Canada, Georgia, Singapore, Spain, Thailand, Australia, Germany, Mexico, Russian Federation, South Africa, Finland, Bosnia and Herzegovina, Bulgaria, Croatia, ... and more
-
Novartis PharmaceuticalsBristol-Myers SquibbRecruitingNon-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma, Marginal Zone LymphomaUnited States, Germany, Italy, Korea, Republic of, Spain, Singapore, China, Japan, Australia
-
Janssen Research & Development, LLCCompletedLymphomaTaiwan, China, Singapore, Korea, Republic of, Hong Kong
-
Samsung Medical CenterCompletedPatients With Diffuse Large B-cell Lymphoma or Follicular Lymphoma | Patients Treated With Rituximab-CHOP or Rituximab-CVPKorea, Republic of, Malaysia, Singapore, China
-
Duke UniversityActive, not recruitingDiffuse Large B Cell LymphomaUnited States, Japan, Italy, Korea, Republic of, Czechia, Singapore
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Nasopharyngeal Keratinizing Squamous Cell Carcinoma | Recurrent Nasopharyngeal Undifferentiated Carcinoma | Stage IV Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 | Adult Nasal Type Extranodal NK/T-Cell Lymphoma | Stage IV Nasopharyngeal Undifferentiated Carcinoma...United States, Singapore, China, Japan
-
National University Hospital, SingaporeRecruitingLymphoblastic Leukemia, Acute, Childhood | Lymphoblastic Leukemia | Lymphoblastic Leukemia, Acute Adult | Lymphoblastic Leukemia in Children | CAR | CAR T-Cell-Related Encephalopathy SyndromeSingapore
-
Regeneron PharmaceuticalsRecruitingB-cell Non-Hodgkin Lymphoma (NHL)United States, Korea, Republic of, China, Spain, Japan, United Kingdom, France, Taiwan, Singapore, Italy, Australia, Canada, Germany, Poland
-
Novartis PharmaceuticalsRecruitingFollicular Lymphoma (FL)Australia, Korea, Republic of, Spain, Singapore, Poland, Taiwan, Hungary, Czechia, Romania, Slovakia
-
Novartis PharmaceuticalsActive, not recruitingNon-Hodgkin LymphomaSpain, Taiwan, Australia, Belgium, Germany, Italy, Singapore, Austria, France, Switzerland, Hong Kong, United States, Netherlands, Norway, United Kingdom, Brazil, China, Japan
-
Novartis PharmaceuticalsActive, not recruitingDiffuse Large B-cell LymphomaSpain, Germany, Canada, Italy, Hong Kong, China, Japan, France, United States, Singapore
-
Bristol-Myers SquibbCompletedLymphoma. Non-HodgkinGermany, Italy, United States, Spain, Netherlands, Australia, United Kingdom, Belgium, France, Canada, Sweden, Singapore
-
BayerActive, not recruitingLymphoma,Non-HodgkinChina, Hong Kong, Spain, Taiwan, Turkey, Japan, Russian Federation, Singapore, France, Austria, Bulgaria, Korea, Republic of, Malaysia, Thailand, United States, Germany, Hungary, Italy, Philippines, Romania, Poland, Portugal, Mexico, ... and more
-
Merck Sharp & Dohme LLCRecruitingFollicular Lymphoma | Mantle Cell Lymphoma | Chronic Lymphocytic Leukemia | Richter Transformation LymphomaPoland, United States, Canada, Chile, China, Estonia, Israel, Italy, Korea, Republic of, Spain, Sweden, Turkey, Czechia, Germany, Brazil, Portugal, Ireland, Singapore, United Kingdom, Japan, Peru
-
PfizerUCB PharmaCompletedLymphoma, B-CellUnited States, France, United Kingdom, Singapore, Korea, Republic of, Germany
-
BayerCompletedDiffuse, Large B-Cell, LymphomaBelgium, France, Canada, Korea, Republic of, Australia, Germany, United Kingdom, Italy, Denmark, Singapore
-
Bristol-Myers SquibbCompletedLymphomaAustralia, Italy, United States, Spain, Canada, United Kingdom, Germany, Belgium, France, Singapore, Sweden, Norway